Cargando…
Modulation of Autophagy is a Potential Strategy for Enhancing the Anti-Tumor Effect of Mebendazole in Glioblastoma Cells
Mebendazole (MBZ), a microtubule depolymerizing drug commonly used for the treatment of helminthic infections, has been suggested as a repositioning candidate for the treatment of brain tumors. However, the efficacy of MBZ needs further study to improve the beneficial effect on the survival of those...
Autores principales: | Jo, Seong Bin, Sung, So Jung, Choi, Hong Seok, Park, Jae-Sung, Hong, Yong-Kil, Joe, Young Ae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622313/ https://www.ncbi.nlm.nih.gov/pubmed/36305295 http://dx.doi.org/10.4062/biomolther.2022.122 |
Ejemplares similares
-
Autophagy Is a Potential Target for Enhancing the Anti-Angiogenic Effect of Mebendazole in Endothelial Cells
por: Sung, So Jung, et al.
Publicado: (2019) -
Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update
por: Chai, Jong-Yil, et al.
Publicado: (2021) -
Enhancing Anti-Cancer Therapy with Selective Autophagy Inhibitors by Targeting Protective Autophagy
por: Lee, Min Ju, et al.
Publicado: (2023) -
Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014) -
Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial
por: Patil, Vijay M., et al.
Publicado: (2022)